Ads
related to: therapy notes reviewstherapynotes.com has been visited by 100K+ users in the past month
Search results
Ocugen completes second cohort dosing in Stargardt trial By Investing.com
Investing.com· 5 days agoThe GARDian trial is designed to evaluate the safety and efficacy of OCU410ST, with the recently...
TScan Therapeutics (NASDAQ:TCRX) Earns Buy Rating from Analysts at BTIG Research
ETF DAILY NEWS· 1 day agoBTIG Research assumed coverage on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports ...
After a Decade of Mental Struggles, This Woman Just Earned the Right to Die
newser· 4 days agoTer Beek's status: The 29-year-old Dutch woman is said to suffer from chronic depression, anxiety,...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoLongeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, is reporting ...
MiNK Therapeutics secures $5.8 million for cancer therapy trials By Investing.com
Investing.com· 7 days agoThe capital is designated for advancing the clinical development of MiNK-215, an innovative cancer ...
GOP Lawmakers In Ohio Finally Approve Rules Allowing Cannabis Sales To Begin In June, Existing...
Benzinga· 7 days agoThe move, undertaken by the Joint Committee On Agency Rule Review (JCARR), puts Ohio adults one step...
Q1 2024 Ocugen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoMusunuri. Shankar Musunuri Thank you, Tiffany, and thank you all for joining us today. As detailed in our press release, we are excited to discuss the substantial progress of our game-changing ...
End-of-life systemic treatment for patients with advanced cancers does not improve survival, finds...
Medical Xpress· 4 days agoPatients with very advanced solid tumors saw no significant improvement in overall survival after...
Q1 2024 Panbela Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoThe early indications from the ASPIRE trial support this belief, and we remain committed to advancing this important study and look forward to sharing the interim results in the first quarter ...
Carisma Therapeutics begins trial for novel cancer therapy By Investing.com
Investing.com· 4 days agoCarisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company, announced today the...
Ads
related to: therapy notes reviewssoftwareadvice.com has been visited by 10K+ users in the past month
